Skip to main content
. 2018 Nov 23;9:583. doi: 10.3389/fpsyt.2018.00583

Table 3.

Selection of Randomized Control Trials and Results Investigating the Efficacy of Therapeutic Interventions (TI's) Versus Control Treatments on Self-Harming Adolescents.

Study Sample Criteria (after attrition) Inclusion Criteria (Self-harm definition) Relevant Diagnostic Tools Outcomes Investigated Treatment Type Periods of Assessment Outcomes and Findings
Treatment/Control (n) Demographics (mean age) Self-Harm Suicidal Ideation Depressive Symptoms Intervention Control
Alavi et al. (27) Iran 15/15 12–18 (16.1) 90% female Hospital presentation following suicide attempt within 3 months of study Scale for Suicidal Ideation (SSI) Hopelessness Inventory (BHI) Depression Inventory (BDI) CBT for suicidal ideation WL 12 weeks Significant reduction in suicidal ideation, hopelessness, and depressive symptoms in treatment group
Asaranow et al. (6) USA 89/92 10–17 (14.7) 69% female Hospital presentation following suicide attempt or suicidal ideation (intentional self-injury with/without intent to die) Suicide attempts on the NIMH-DISC-IV Center for Epidemiological Studies Depression Scale (CES-D) Family Intervention for Suicide Prevention (FISP) TAU ~2 months No significant reduction in self-harm or depressive symptoms, but improved linkage to outpatient care
Asarnow et al. (31) USA 20/22 11–18 (14.62) 88% female Suicide attempt within 3 months of study or ≥3 episodes of self-harm within lifetime Columbia-Suicide Severity Rating Scale (C-SSRC) NIMH-DISC-IV Suicide History Interview (SHI) Service assessment for children and Adolescents (SACA) SAFETY (DBT informed CBT) E-TAU 3 months Significant differences between groups for SA at 30month timepoint, no difference between groups on NSSI.
Chanen et al. (33) Australia 44/42 15–18 (16.4) 76% female Fulfillment of 2/9 DSM-IV Criteria for Borderline Personality Disorder Semi-structured interview for paras-suicidal behavior developed by research group Cognitive Analytic Therapy GCC 6, 12, 24 months Reduction of parasuicidal behaviors seen within whole cohort, with no significant group differences
Cotgrove et al. (35) UK 47/58 ≤ 16 (14.9) 85% female Hospital presentation following suicide attempt (attempted suicide, deliberate acts of self-injury or self-poisoning) Clinical records Questionnaire, unspecified Token for readmission to hospital + AAU AAU 12 months Fewer people (50%) with hospital readmission tokens re-attempt suicide than those without, but no significant effect found within treatment group
Diamond et al. (38) USA 35/31 12–17 (15.1) 83% female >31 SIQ score >20 BDI-II Suicide Ideation Questionnaire (SIQ-JR) Beck Depression Inventory (BDI-II) Scale for Suicidal Ideation (SSI) Attachment-based Family Therapy E-TAU 6, 12, 24 weeks Significant reduction in SI within treatment group at all-time points; Significant reduction in DS within treatment group my mid-treatment, but loss of effect at post-treatment and follow-up
Donaldson et al. (38) USA 21/18 12–17 (15) 82%female Hospital presentation following suicide attempt (intentional non-fatal self-injury with intent to die) Structured Follow-up Interviews SIQ CES-D Skills-Based Treatment (SBT) SRT 3, 6 months Overall reduction in likelihood of re-attempting suicide and an improvement in ideation and depressive symptoms, but no significant differences between groups at any point
Esposito-Smythers et al. (28) USA 20/20 13–17(15) 68% female Suicide attempt within 3 months of study or41 on SIQ in the past month SIQ Columbia Impairment Scale (CIS) Reynolds Adolescent Depression Scale (RADS-2) I-CBT E-TAU 18 months Significant reduction in suicide attempts in treatment condition; overall improvement in cohort on ideation and depressive symptoms with no significant differences between groups
Green et al. (23) UK 179/180 12–17 89% female Hospital presentation following2 episodes of self-harm within 12 months (intentional self-inflicted injuries or overdose of toxic substances) SIQ Mood and Feeling Questionnaire (MFQ) Health of Nation Outcomes Scales for Children and Adolescents (HoNOSCA) Developmental Group Psychotherapy TAU 6,12 months Overall improvement within cohort on self-harm, ideation and depressive symptoms, but no significant differences between groups at any point
Harrington et al. (36) UK 85/77 ≤ 16 (14.5) 90% female Hospital presentation following deliberate self-poisoning (ingestion of substances not for human consumption, or overdose) SIQ Hopelessness Questionnaire McMaster Family Assessment Device Home-based Family Intervention + TAU TAU 2, 6 months No significant differences between groups at any point on rates of suicidal ideation
Hazell et al. (22) Australia 35/37 12–16 (14.5) 91% female 3 episodes of self-harm, one happening within 1 month of study (intentional self-inflicted injury irrespective of intent) SIQ MFQ Schedule for Affective Disorders and Schizophrenia (K-SADS) HoNOSCA Developmental Group Psychotherapy TAU 2, 6, 12 months Overall improvement within cohort on self-harm, ideation, and depressive symptoms but no significant differences between by follow-up; Significantly higher proportion of treatment group engaged in self-harm until 6 months
King et al. (39) USA 113/123 12–17 (15.3) 68% female Significant suicidal ideation or suicide attempt with 1 month of study / score of 20 or 30 on Self-harm subscale of the Child and Adolescent Functional Assessment Scale (CAFAS) SIQ-JR Spectrum of Suicide Behavior Scale Youth Self-Report (YSR) RADS CAFAS YST-I + TAU TAU 6 months No significant difference in suicide attempts between groups. Small to medium effect on the reduction of suicidal ideation only after altering analyses from intent-to-treat to only in female participants
King et al. (40) USA 223/225 13–17 (15.6) 71% female Significant suicidal ideation or suicide attempt within 4 weeks of study SIQ-JR BHS Children's Depression Rating Scale Revised (CDRS-R) YST-II + TAU TAU 6 weeks, 3, 6, 12 months No significant reduction in suicide attempts. Overall improvement on depressive symptoms (moderated by multiple attempts) lasting 6 weeks.
Mehlum et al. (42) Norway 39/38 (15.6) 83% female 1 episode of self-harm within 16 weeks of study / Fulfillment of 2 criteria of BPD / fulfillment of 1 + 2 subthreshold criteria of BPD (intention self-inflicted injury irrespective of intent) Lifetime Parasuicide Count (LPC) Interview Suicide Intent Scale (SIS) SIQ-JR Short MFQ DBT-A E-TAU 9, 15, 19, 71 weeks Significant reduction in self-harm, ideation, and depressive symptoms at 19 weeks, but loss of significance at 1 year follow-up;
Ougrin et al. (34) UK 35/34 12–18 (15.5) 80% female Engaging in self-harm without prior involvement with psychiatric services (intentional self-inflicted injury or self-poisoning irrespective of intent) Health department records including: CAMHS, A&E, and Primary Care Therapeutic Assessment (TA) AAU 24 months No significant reduction in hospital presentations for self-harm, though treatment engagement increased significantly
Pineda and Dadds (41) Australia 22/18 12–17 (15.14) 75% female 1 episode of suicidal behavior (suicidal ideation, intent, suicide attempt, self-injury) within the last 2 months before referral to hospital; residing with at least 1 parent Adolescent Suicide Questionnaire- Revised (ASQ-R) RAP-P Routine Care 3, 6 months Significant improvement in suicidal behavior at 3 and 6 months in RAP-P group, compared to control group.
Rossouw et al. (32) UK 20/20 12–17 (14.7) 80% female 1 episode of self-harm within past month (intentional self-inflicted injury irrespective of intent) Risk-Taking and Self-Harm Inventory (RTSHI) MFQ MBT-A TAU 3, 6, 9, 12 months Significant reduction in self-harm and depressive symptoms for treatment group during treatment and at follow-up
Schuppert et al. (26) Holland 23/20 14–19(16.14) 88% female Fulfillment of 2/9 DSM-IV Criteria for Borderline Personality Disorder including: Recurrent suicidal behavior, gestures, threats, or self-mutilation Clinical interview Youth Self-Report (YSR) Internalizing & Externalizing Emotion Regulation Training + TAU TAU 3, 6 months Reduction in self-harm and depressive symptoms seen within whole cohort with no significant group differences
Schuppert et al. (25) Holland 54/55 14–19 (15.98) 96% female Fulfillment of 2/9 DSM-IV Criteria for Borderline Personality Disorder including: Recurrent suicidal behavior, gestures, threats, or self-mutilation Clinical interview Youth Self-Report (YSR) Internalizing & Externalizing Emotion Regulation Training + TAU TAU 6, 12 months Reduction in self-harm and depressive symptoms seen within whole cohort with no significant group differences (information obtained via e-mail)
Wharff et al. (37)USA 68/71 13–18 (15.5) 72% female Hospital presentation for suicidality (suicidal self-identification, adult-noted suicidality, suicide attempt) Reasons for Living Inventory for Adolescents (RFL-A) Family-Based Crisis Intervention TAU Post-test, 3 day, 1 week, 1 month Overall reduction of ideation and depressive symptoms within whole cohort with no significant group differences; Intervention group significantly less likely to be re-hospitalized post treatment
Wood et al. (24) UK 32/31 12–16 (14.25) 78% female Hospital presentation following incident of self-harm (intentional self-inflicted injury irrespective of intent) MFQ SIQ HoNOSCA Developmental Group Psychotherapy TAU 7 months Significant reduction in likelihood of re-attempting suicide within treatment group; overall improvement within cohort but no treatment effect on ideation and depressive symptoms

TAU, Treatment As Usual; E-TAU, Enhanced Treatment As Usual; GCC, Good Clinical Care; AAU, Assessment As Usual; SDP, Standard Disposition Planning; SRT, Supportive Relationship Treatment; I-CBT, Integrated CBT.